CClinicalTrials.gg
Not yet recruitingNCT07326241Updated Jan 8, 2026

Effects of Silver Diamine Fluoride and Intraoral Cryotherapy on Local Anesthesia in MIH-Affected Molars

An interventional study of Standard Local Anesthesia and Intraoral Cryotherapy in MIH, Molar-Incisor Hypomineralization and Caries Assessment, sponsored by Çanakkale Onsekiz Mart University. Not yet recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Çanakkale Onsekiz Mart University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Molar-incisor hypomineralization (MIH) is a developmental enamel defect of unclear etiology that affects permanent first molars and often permanent incisors, leading to increased porosity, hypersensitivity, and poor prognosis. The porous structure of MIH-affected enamel facilitates bacterial penetration, which may cause subclinical pulpal inflammation and reduce the effectiveness of local anesthesia during dental procedures. Achieving adequate anesthesia in children with MIH can be challenging, resulting in increased discomfort, anxiety, and behavioral management difficulties.

Cryotherapy has been shown to reduce pain by decreasing local inflammation and slowing nerve conduction, while silver diamine fluoride (SDF) has demonstrated efficacy in reducing dentin hypersensitivity through tubule occlusion, antibacterial activity, and remineralization. This study aims to evaluate the effects of intraoral cryotherapy and silver diamine fluoride application on pain perception and the efficacy of local anesthesia during operative dental procedures in MIH-affected permanent first molars.

Read the detailed description

The porous enamel structure of MIH-affected teeth facilitates bacterial penetration into enamel and dentin, which may lead to subclinical inflammatory reactions within the dentin-pulp complex. This inflammatory status has been associated with reduced effectiveness of local anesthesia during restorative dental procedures. In pediatric patients, difficulty in achieving adequate anesthesia may result in increased discomfort during treatment, contributing to dental anxiety, negative behavioral responses, and the need for repeated treatment sessions. Therefore, improving anesthetic efficacy in MIH-affected teeth is essential for both patient comfort and treatment quality.

Cryotherapy is a well-established method for pain management in medical practice. Its analgesic effect is attributed to reduced local inflammation, decreased nerve conduction velocity, and minimization of edema and bleeding. Previous studies have demonstrated that the use of cryotherapy following mandibular block anesthesia may reduce pain perception during dental treatment compared to conventional anesthesia alone.

Silver diamine fluoride (SDF) is a solution containing silver and fluoride ions that has been shown to effectively reduce dentin hypersensitivity by occluding dentinal tubules, promoting remineralization of demineralized tooth structure, and exerting antibacterial effects. SDF stabilizes active carious lesions and reduces sensitivity through the formation of fluorohydroxyapatite and tubule blockage. It was approved by the U.S. Food and Drug Administration in 2014 for the treatment of dentin hypersensitivity. Given its desensitizing properties, SDF may be a promising adjunctive approach to enhance anesthetic effectiveness in MIH-affected molars.

This study aims to evaluate the effects of intraoral cryotherapy and silver diamine fluoride application on pain perception and the efficacy of local anesthesia during operative dental procedures in permanent first molars affected by MIH. Pediatric patients presenting for examination and treatment at the Department of Pediatric Dentistry will be allocated into three groups: a control group, a cryotherapy group, and an SDF group. Prior to treatment, demographic and dental characteristics will be recorded, and baseline pulp sensibility responses will be assessed using electric cold testing and air stimulation (SCASS).

All treated teeth will receive local anesthesia using a standardized mandibular block technique. In the SDF group, SDF will be applied prior to anesthetic administration. In the cryotherapy group, cold application will be performed on the buccal mucosa for 5 minutes using frozen saline contained in 2-mL dental syringes wrapped in sterile gauze before treatment. Following local anesthesia, caries removal and final composite resin restorations will be completed. Pain intensity and behavioral responses during treatment will be assessed using validated pediatric pain scales. The total duration of the clinical procedure is planned to be approximately 45 minutes.

02

Conditions studied

  • MIH
  • Molar-Incisor Hypomineralization
  • Caries Assessment
03

In context

Molar Hypomineralization

121 studies on the registry are indexed under Molar Hypomineralization; 41 are open to participants now.

This study's planned enrollment of 75 is above the median of 52 across 94 interventional studies indexed under Molar Hypomineralization.

Browse Molar Hypomineralization studies →

Lead sponsor

Çanakkale Onsekiz Mart University is the lead sponsor of 50 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged between 6 and 12 years.
  • Systemically healthy children with no medical conditions that could interfere with dental treatment.
  • Presence of at least one permanent first molar affected by molar-incisor hypomineralization (MIH), diagnosed according to the European Academy of Paediatric Dentistry (EAPD) criteria.
  • Teeth with caries lesions classified as ICDAS II codes 2, 3, 4, 5, or 6.
  • Children with an adequate level of cooperation to allow completion of dental treatment under clinical conditions.
  • Children and their parents/legal guardians who have read, understood, and signed the informed consent form and agreed to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Teeth that are not restorable.
  • Children with a known allergy or hypersensitivity to any materials used in the study, including local anesthetics, silver diamine fluoride, or restorative materials.
  • Presence of spontaneous pain, percussion sensitivity, or other signs/symptoms of pulpal pathology in the study tooth.
  • Children with systemic diseases or conditions that could affect pain perception, healing, or cooperation during dental treatment.
  • Children who are unable or unwilling to complete the clinical procedure.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Control (Standard Local Anesthesia)

    Standard local anesthesia and operative restorative treatment only (no adjunctive SDF or cryotherapy).

    Other: Standard Local Anesthesia

  • Experimental
    Intraoral Cryotherapy + Standard Local Anesthesia

    Intraoral cryotherapy applied before anesthesia, followed by standard local anesthesia and operative restorative treatment.

    Other: Standard Local Anesthesia · Other: Intraoral Cryotherapy

  • Experimental
    Silver Diamine Fluoride (SDF) + Standard Local Anesthesia

    Silver diamine fluoride applied before anesthesia, followed by standard local anesthesia and operative restorative treatment.

    Other: Standard Local Anesthesia · Other: Silver Diamine Fluoride (SDF)

Interventions

  • OtherStandard Local Anesthesia

    Local anesthesia will be administered using 1.8 mL articaine HCl with 1:100,000 epinephrine (e.g., Ultracain DS) via a standardized block anesthesia technique prior to operative treatment. (Applied in

  • OtherIntraoral Cryotherapy

    Cold application to the buccal mucosa adjacent to the treated tooth for 5 minutes before local anesthetic administration.

  • OtherSilver Diamine Fluoride (SDF)

    SDF will be applied to the target tooth before local anesthetic administration according to standard clinical application procedures.

06

What researchers measure

Primary outcomes

  1. Pain intensity during dental treatment (FLACC)

    Face, Legs, Activity, Cry, Consolability scale will be recorded. Each category is scored on the 0 to 2 scale. Add the scores together (for a total possible score of 0 to 10).

    Time frame: Immediately after completion of the dental procedures

  2. Pain intensity during operative dental treatment (Wong-Baker)

    The patient's current pain was assessed using the Wong-Baker Faces Pain Rating Scale, with scores ranging from 0 to 5, where higher scores indicate greater pain intensity and a worse outcome, and the assessment was performed immediately after completion of the dental procedures.

    Time frame: Immediately after the dental procedures were completed

07

Study locations

2 sites
  • Çanakkale Onsekiz Mart University, School of Dentistry
    Çanakkale, Turkey (Türkiye)
  • Mersin University, School of Dentistry
    Mersin, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07326241
Lead sponsor
Çanakkale Onsekiz Mart University
Collaborators
Mersin University
Responsible party
Burak Carıkcıoglu (Associate Professor, Çanakkale Onsekiz Mart University) — Principal investigator
First posted
Jan 8, 2026
Start date
Feb 1, 2026 (estimated)
Primary completion
Mar 15, 2026 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Jan 8, 2026

Study contacts

Burak Çarıkçıoğlu, Associate Professor
Contact
carikcioglub@gmail.com
+905054956091
Hilal Öztürk, Research Assistant
Contact
hilalozturk98@gmail.com
+905312591404
Burak Çarıkçıoğlu, Associate Professor
principal investigator · Çanakkale Onsekiz Mart University
Seçkin Aksu, Assistant Professor
study director · Mersin University
Hilal Öztürk, Research Assistant
study chair · Çanakkale Onsekiz Mart University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion